$FABC Income Statement | Understand Stock

$FABC

$2.04 +$0.08 (4.08%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenue
Cost of goods sold
Gross loss
Operating expenses:
Research and development
Sales and marketing
General and administrative
Loss on impairment of long-lived assets
Total operating expenses
Loss from operations
Other income (expense):
Interest expense
Interest income
Change in fair value - warrant liability
Change in fair value - derivative liability
Unrealized loss on digital assets
Unrealized gain (loss) on marketable securities
Realized gain on marketable securities
Legal settlement
Vendor settlement
Consent and waiver fee - Series H-7
Other income (expense), net
Total other income (expense), net

Net income (loss) prior to provision for income taxes
Deemed dividend on modification of Series H-5 warrants
Net income (loss)
Dividends earned on Series H-7 convertible preferred stock
Deemed dividend (Series H-5 warrants)
Accretion of discounts to redemption value of Series H-7 convertible preferred stock
Net loss attributable to common stockholders
Net loss per share, basic and diluted
Net loss per share basic
Basic and diluted weighted average Common Stock outstanding
Net loss per share diluted
Basic weighted average Common Stock outstanding
Diluted weighted average Common Stock outstanding

Comments